DAC-SpectroMed s

DAC-SpectroMed s.r.l.
-2012,
, .
, .
.:/+37322/ 574900,574922/23;
«in vitro»
, 47, . 64
: /+37322/ 574920
2-80
Email: office@dacspectromed.com
www.dacspectromed.com
SLE-DAC
(
)
PT MD 11-38623324-001:2002
1043S100
SLE-Reagent –
,
(DNP),
SLE-Positive Control –
,
SLE-Negative Control –
,
Diluent 0,9 % –
1 ml
0,95 g/l
,
0,100 ml
0,95 g/l
,
0,95 g/l
9 g/l,
0,100 ml
0,95 g/l
5 ml
1 .
50 .
.
,
,
HIV,HCV
.
,
(DNP),
-DNP
HBs-
-
.
-DNP
«
,
.
»,
.
2-
:
18-220
(
(
),
SLE-Reagent
)
(
.
).
(
2-80
1.
,
.
!
10
)
:
l
10 l SLE-Reagent.
2.
,
.
3.
.
2-8
–1
0
48
.
,
1
20
4.
10 l,
26.11.2013
.
,
.
1
.
20-50
l.
).
(80-100
.
1
:
1.
2.
50 l
.
,
,
SLE-Reagent.
1
SLE-
.
,
,
.
)
1.
6
155
23
).
2.
3.
0,1 ml Diluent.
0,1 ml
1
,
,
8
,
.
.
1 : 2
29
95
.
SLE-Latex
LE29
Latex
,
4.
1 0,1 ml .
:
2
1 : 64.
.
ANA-
.
, SLE-
82%
LE-
86%
82 %
ANA-
5.
.
.
23
–
-
(
),
1
ANA-
, SLE-Latex
,
- 71%
19%
LE-
.
–
(
-
SLE-Latex
),
,
,
1
19%
.
17%
.
50%
:
LE, ANA-
.
,
,
,
.
1%
SLE-Latex
LE-
.
Positive
SLE-Reagent, SLE–
SLE–Negative Control
.
Control
,
- DNP
(Systemic Lupus Erythematosus, SLE)
LEin vitro.
75-80 %
.
,
,
26.11.2013
ANA-
6%
.
,
,
-
1. Christian C.L., R. Mendez-Bryan, and D.L. Larson, 1958.
Proc.Soc.Exptl.Biol.Med.98 , 820-823.
2. Friou, G.J., S.C. Finch, and K.D, Detre, 1958.
J.Immunol.80, 324-329.
3. Hargraves, m. M., H. Richmond, and R. Morton, 1948.
Proc. Mayo Clin. 23 25-28.
4. Holman, H.R, and H.G. Kunkel, 1957. Science 126, 163.
5. Miescher, P.A., and R.Strassel, 1957.Vox.Sang, 2 283-287.
6. Miescher, P.A., Rothfield, and A.Miescher, 1966. Lupus
Erythematosus, E.L. Dubois, Ed., Blakiston Co, N.Y.
6. Rothfield, N.F., J.J.Phythyon, C.McEwen, and P. Miescher,
1961. Arthritis Rheum. 4, 223-229.
7. Benett, R.M., B.Langer, and E. Molina, 1976.
Am.J.Clin.Path. 66 743-745.
9. Chapman, J.C., 1976. Am.J.Med.Tech.42 154-157.
26.11.2013
10. Tuffanelli, D.L., 1972. arch Derm., 106 553-566.